Allspring Global Investments Holdings, LLC Reneo Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$5.44 - $8.13 $2,856 - $4,268	525 New	525 $4,000
Q2 2022 Jul 25, 2022	SELL	$1.96 - $3.04 $4,451 - $6,903	-2,271 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$6.07 - $9.68 $13,784 - $21,983	2,271 New	2,271 $19,000

Others Institutions Holding RPHM

# of Institutions

Shares Held

31M

Call Options Held

50.8K

Put Options Held

Nea Management Company, LLC Timonium, MD

4.79M
Shares

$8.04 Million
0.62% of portfolio
Bml Capital Management, LLC Zionsville, IN

3.46M
Shares

$5.81 Million
3.46% of portfolio
Highbridge Capital Management LLC New York, NY

3.06M
Shares

$5.15 Million
1.56% of portfolio
Tang Capital Management LLC San Diego, CA

2.95M
Shares

$4.95 Million
0.43% of portfolio
Carlyle Group Inc. Washington, DC

2.7M
Shares

$4.53 Million
0.69% of portfolio

View Full List

About Reneo Pharmaceuticals, Inc.

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

More about RPHM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account